Spinraza (Nusinersen)
- Medicine name: Spinraza
- Generic name: Nusinersen
- Dosage form & strength: 12 mg/5 mL (2.4 mg/mL) in a single-dose vial
- Manufactured by: Ionis Pharmaceuticals, Inc.
Coagulation abnormalities and thrombocytopenia, including severe acute thrombocytopenia, have been observed after the administration of some antisense oligonucleotides. Because of the risk of thrombocytopenia and coagulation abnormalities from Spinraza, patients may be at increased risk of bleeding complications. One should perform a platelet count and coagulation laboratory testing at baseline and before each administration of Spinraza and as clinically needed.
Renal toxicity, including potentially fatal glomerulonephritis, has been observed after the administration of some antisense oligonucleotides. One should conduct quantitative spot urine protein testing (preferably a first-morning urine specimen) at baseline and before each dose of Spinraza. Consider repeat testing and further evaluation for urinary protein concentration greater than 0.2 g/L.
What documents are required to import Spinraza to India?
Spinraza (Nusinersen) injections can be imported only by patients or government hospitals in the patients’ name.
The following documentation is needed to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Identity proof (issued by Govt of India)
How does the order confirm?
The order will be confirmed only after the receipt of:
- A valid prescription by healthcare professionals.
- Import permit if applicable.
Is Spinraza available in India?
Spinraza (Nusinersen) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Spinraza injection in India.
- Medicine Price.
- Finding Genuine and reliable sources from Canada, Europe, the USA and Australia
- Ensuring 100% transparency.
Spinraza can be made available to patients, doctors and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order for Spinraza will be confirmed only after receiving a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of Spinraza (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable)
Please get in touch with +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at info@indianpharmanetwork.in for Spinraza price in India.
We guarantee quality and delivery anywhere in the world per the buyer’s requirements.
Indian Pharma Network can source the Spinraza from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
How do Spinraza work?
Spinraza is an antisense oligonucleotide designed to treat SMA caused by mutations in chromosome 5q that lead to SMN protein deficiency. According to in vitro assays and studies in transgenic animal models of SMA, Spinraza was shown to increase exon 7 inclusion in SMN2 messenger ribonucleic acid (mRNA) transcripts and the production of full-length SMN protein.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.